Midkine, a potential link between obesity and insulin resistance

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Syndrome

Background:

• Obesity drives chronic inflammation and insulin resistance via adipose tissue mediators.
• Midkine (MK) is a growth factor with known pro-inflammatory properties.

Purpose of the Study:

• To investigate the association of Midkine (MK) with obesity.
• To determine the role of MK in the development of insulin resistance.

Main Methods:

• Assessed MK expression in adipocytes and its regulation by TNF-α and rosiglitazone.
• Measured MK levels in adipose tissue of obese mice and serum of overweight/obese humans.
• Evaluated MK's effect on insulin signaling pathways (Akt, IRS-1, GLUT4) in 3T3-L1 adipocytes.
• Investigated MK's impact on the STAT3-SOCS3 pathway in adipocytes.

Main Results:

• MK is expressed in adipocytes and modulated by inflammatory factors.
• Elevated MK levels were found in obese mice adipose tissue and overweight/obese human serum.
• MK inhibited insulin signaling by reducing Akt/IRS-1 phosphorylation and GLUT4 translocation.
• MK activated the STAT3-SOCS3 pathway in adipocytes.

Conclusions:

• Midkine (MK) is a novel adipocyte-secreted factor linked to obesity.
• MK contributes to insulin resistance by impairing insulin signaling in adipocytes.
• MK represents a potential molecular link between obesity and insulin resistance.